Pharmaceutical PV DIV - FSB
Ended Awarded
- Contract number
- SPE2DU26FENWS
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,754
Award facts
- Contract value 100% obligated
- $10,754.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,754.46 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, issued on October 28, 2025, represents a routine procurement under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The award carries no set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group serves as a critical pharmaceutical supplier within the Department of Defense's medical supply chain, providing branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables to support military healthcare operations.
This delivery order is issued under the PPV-G GEN V acquisition vehicle, a $30.3 billion government-wide pharmaceutical supply program designed to provide Department of Defense healthcare facilities with a comprehensive range of pharmaceutical products on a recurring basis. DMS Pharmaceutical Group holds a single-award Indefinite Delivery Contract under this vehicle with a $500 million ceiling value and completion date of December 31, 2036, positioning the company as one of multiple regional prime vendor contractors. The contractor operates independently with no identified subcontractors and has demonstrated substantial performance on numerous delivery orders issued by the Defense Logistics Agency's Medical Supply Chain division, establishing its reliability as a federal pharmaceutical supplier.
Quick answers
Who was awarded contract SPE2DU26FENWS?
SPE2DU26FENWS was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 28, 2025.
How much is contract SPE2DU26FENWS worth?
The government has obligated $10,754 on SPE2DU26FENWS.
Is contract SPE2DU26FENWS an order under another contract?
Yes. SPE2DU26FENWS is a delivery order under SPE2DU25D9418, an indefinite delivery contract.
Was contract SPE2DU26FENWS competed?
The extent of competition for SPE2DU26FENWS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award